Analyst Ratings for Takeda Pharmaceutical (TAK)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/16/2023 | BofA Securities » Updated 6/13/2023 |
Koichi Mamegano | Upgrade | Buy (Neutral) |
18.60 (20.00) |
16.08 (15.82) |
-1.62% | Details |
| 7/19/2022 | TD Cowen » Updated 5/21/2025 |
Michael Nedelcovych | Upgrade | Buy (Hold) |
16.00 (N/A) |
14.41 (15.82) |
9.78% | Details |
